Genetic Polymorphisms in Drug-Metabolizing Enzymes and Drug Targets
Data up to Jan 2025
Total Citations Per Year
Abstract
References (92)
An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.
1990 • 3,809 citations
Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity.
1980 • 1,185 citations
Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels.
1992 • 1,181 citations
The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans.
1994 • 958 citations
Amino-Terminal Polymorphisms of the Human .beta.2-Adrenergic Receptor Impart Distinct Agonist-Promoted Regulatory Properties
1994 • 780 citations
Molecular Diagnosis of Thiopurine S-Methyltransferase Deficiency: Genetic Basis for Azathioprine and Mercaptopurine Intolerance
1997 • 765 citations
Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese.
1994 • 749 citations
Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile.
1987 • 720 citations
N-acetylation pharmacogenetics.
1985 • 637 citations
The Role of a Common Variant of the Cholesteryl Ester Transfer Protein Gene in the Progression of Coronary Atherosclerosis
1998 • 634 citations
Mutations in the Gene Encoding for the β2-adrenergic Receptor in Normal and Asthmatic Subjects
1993 • 633 citations
The role of the CFP2C9-Leu 359 allelic variant in the tolbutamide polymorphism
1996 • 584 citations
Genotypes for aldehyde dehydrogenase deficiency and alcohol sensitivity. The inactive ALDH2(2) allele is dominant.
1989 • 579 citations
Biochemistry and molecular biology of the human CYP2C subfamily
1994 • 534 citations
Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9
1994 • 500 citations
RESPONSE: Re: Modification of Clinical Presentation of Prostate Tumors by a Novel Genetic Variant in CYP3A4
1999 • 478 citations
Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations
1985 • 459 citations
Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells.
1995 • 443 citations
Molecular abnormality of an inactive aldehyde dehydrogenase variant commonly found in Orientals.
1984 • 442 citations
Geographical/Interracial Differences in Polymorphic Drug Oxidation
1995 • 431 citations
Human ArylamineN-Acetyltransferase Genes: Isolation, Chromosomal Localization, and Functional Expression
1990 • 429 citations
Population study of dihydropyrimidine dehydrogenase in cancer patients.
1994 • 428 citations
Nomenclature for human CYP2D6 alleles
1996 • 406 citations
The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes
1990 • 387 citations
Dihydropyrimidine dehydrogenase activity in human peripheral blood mononuclear cells and liver: population characteristics, newly identified deficient patients, and clinical implication in 5-fluorouracil chemotherapy.
1993 • 371 citations
The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations
1999 • 362 citations
Modification of Clinical Presentation of Prostate Tumors by a Novel Genetic Variant in CYP3A4
1998 • 348 citations
CYP3A4 allelic variants with amino acid substitutions in exons 7 and 12: Evidence for an allelic variant with altered catalytic activity
2000 • 346 citations
Thiopurine S-methyltransferase deficiency: two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians.
1996 • 321 citations
Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction.
1995 • 313 citations
A single point mutation leading to loss of catalytic activity in human thiopurine S-methyltransferase.
1995 • 303 citations
A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles.
1995 • 293 citations
Clinical significance of the sparteine/debrisoquine oxidation polymorphism
1989 • 292 citations
Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirement in patients undergoing anticoagulation therapy
1995 • 280 citations
Polymorphism of the thiopurine S-methyltransferase gene in African- Americans
1999 • 272 citations
Racial differences in alcohol sensitivity: A new hypothesis
1979 • 259 citations
Allelic Variants of Human Cytochrome P450 2C9: Baculovirus-Mediated Expression, Purification, Structural Characterization, Substrate Stereoselectivity, and Prochiral Selectivity of the Wild-Type and I359L Mutant Forms
1996 • 256 citations
Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms
1996 • 246 citations
Thiopurine methyltransferase alleles in British and Ghanaian populations
1999 • 245 citations
Thiopurine methyltransferase activity in American white subjects and black subjects
1994 • 241 citations
N-acetyltransferase
1989 • 237 citations
Five of 12 forms of vaccinia virus-expressed human hepatic cytochrome P450 metabolically activate aflatoxin B1.
1990 • 236 citations
A tobacco smoke-derived nitrosamine, 4-(methytnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytocbrome P450s including the polymorphic human cytochrome P4502D6
1991 • 235 citations
Debrisoquine/Sparteine Hydroxylation Genotype and Phenotype: Analysis of Common Mutations and Alleles ofCYP2D6in a European Population
1991 • 224 citations
Metoprolol and mephenytoin oxidation polymorphisms in Far Eastern Oriental subjects: Japanese versus mainland Chinese
1989 • 221 citations
Cloning and expression of cDNAs for polymorphic and monomorphic arylamine N-acetyltransferases from human liver.
1990 • 217 citations
Heterogeneity at theCETPGene Locus
1997 • 212 citations
Characterisation and PCR‐based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population
1999 • 207 citations
Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily
1991 • 200 citations
Detection of CYP2C9 polymorphism based on the polymerase chain reaction in Chinese
1995 • 195 citations
Cloning of cDNAs for human aldehyde dehydrogenases 1 and 2.
1985 • 194 citations
Identification of the human liver cytochrome P-450 responsible for coumarin 7-hydroxylase activity
1990 • 193 citations
Known variant DPYD alleles do not explain DPD deficiency in cancer patients
2000 • 184 citations
DNA polymorphism at the locus for human cholesteryl ester transfer protein (CETP) is associated with high density lipoprotein cholesterol and apolipoprotein levels
1989 • 182 citations
Serotonin, schizophrenia and antipsychotic drug action
1995 • 172 citations
Characterization of the Human Dihydropyrimidine Dehydrogenase Gene
1998 • 167 citations
Ethnic differences in thiopurine methyltransferase pharmacogenetics
1999 • 167 citations
Interindividual variability of coumarin 7-hydroxylation in healthy volunteers
1992 • 165 citations
Human cytochrome P450IIA3: cDNA sequence role of the enzyme in the metabolic of promutagens comparison to nitrosamine activation by human cytochrome P450IIE1
1990 • 145 citations
Effects of changing glutamate 487 to lysine in rat and human liver mitochondrial aldehyde dehydrogenase. A model to study human (Oriental type) class 2 aldehyde dehydrogenase.
1994 • 145 citations
Roles of Cytochrome b5in the Oxidation of Testosterone and Nifedipine by Recombinant Cytochrome P450 3A4 and by Human Liver Microsomes
1996 • 140 citations
Human kidney thiopurine methyltransferase purification and biochemical properties
1983 • 132 citations
Dihydropyrimidine dehydrogenase pharmacogenetics in Caucasian subjects
1998 • 126 citations
Lack of association between polymorphisms in the 5-HT2A receptor gene and the antipsychotic response to clozapine
1996 • 125 citations
Human thiopurine methyltransferase pharmacogenetics. Kindred with a terminal exon splice junction mutation that results in loss of activity.
1998 • 118 citations
Detection of known and new mutations in the thiopurineS-methyltransferase gene by single-strand conformation polymorphism analysis
1998 • 112 citations
A new deleted allele in the human cytochrome P450 2A6 (CYP2A6) gene found in individuals showing poor metabolic capacity to coumarin and (+)-cis-3,5-dimethyl-2-(3 -pyridyl)thiazolidin-4-one hydrochloride (SM-12502)
1998 • 111 citations
A novel transversion in the intron 5 donor splice junction of CYP2C19 and a sequence polymorphism in exon 3 contribute to the poor metabolizer phenotype for the anticonvulsant drug S-mephenytoin.
1999 • 109 citations
The stereoselective metabolism of fluoxetine in poor and extensive metabolizers of sparteine
1999 • 101 citations
Nomenclature for human DPYD alleles
1998 • 96 citations
A new CYP2A6 gene deletion responsible for the in vivo polymorphic metabolism of (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride in humans.
1999 • 96 citations
Dihydropyrimidine dehydrogenase pharmacogenetics in patients with colorectal cancer
1998 • 92 citations
Metoprolol oxidation polymorphism in a Korean population: comparison with native Japanese and Chinese populations.
1991 • 89 citations
Genetic analysis of thiopurine methyltransferase polymorphism in a Japanese population
2000 • 87 citations
Comparison of a novel thin-layer chromatographic—fluorescence detection method with a spectrofluorometric method for the determination of 7-hydroxycoumarin in human urine
1992 • 87 citations
Effect of the Insertion/Deletion Polymorphism of the Angiotensin-Converting Enzyme Gene on Response to Angiotensin-Converting Enzyme Inhibitors in Patients with Heart Failure
1998 • 82 citations
Perspectives on the role of serotonergic mechanisms in the pharmacology of schizophrenia
1997 • 82 citations
Genotyping of N-acetylation polymorphism and correlation with procainamide metabolism*
1997 • 78 citations
Identification of novel mutations in the dihydropyrimidine dehydrogenase gene in a Japanese patient with 5-fluorouracil toxicity.
1998 • 73 citations
Interindividual variability of coumarin 7-hydroxylation in a Turkish population
1994 • 69 citations
Structural organization of the human dihydropyrimidine dehydrogenase gene.
1997 • 67 citations
Analysis of neuroleptic binding affinities and potencies for the different human D2 dopamine receptor missense variants
1999 • 67 citations
Purine substrates for human thiopurine methyltransferase
1994 • 65 citations
5-HT2 receptor gene locus: association with schizophrenia or treatment response not detected.
1996 • 57 citations
The D5 dopamine receptor gene in schizophrenia: identification of a nonsense change and multiple missense changes but lack of association with disease
1995 • 56 citations
Evidence for polymorphic oxidation of sparteine in Japanese subjects.
1987 • 55 citations
Functional analysis of the human D5 dopamine receptor missense and nonsense variants: differences in dopamine binding affinities.
1999 • 50 citations
5-HT2 receptor gene locus
1996 • 50 citations
Genetic polymorphism of drug metabolizing enzymes: new mutations in CYP2D6 and CYP2A6 genes in Japanese.
1998 • 48 citations
A new variant CYP2D6 allele (CYP2D6*21) with a single base insertion in exon 5 in a Japanese population associated with a poor metabolizer phenotype
1999 • 48 citations
Metabolic and genetic control of HDL cholesterol levels
1992 • 46 citations
Scanning of the dopamine D1 and D5 receptor genes by REF in neuropsychiatric patients reveals a novel missense change at a highly conserved amino acid
1998 • 41 citations